Sage Therapeutics Inc. sell StockNews.com
Start price
20.04.24
/
50%
€12.32
Target price
20.04.25
-
Performance (%)
-49.19%
Price
02.10.24
€6.31
Summary
This prediction is currently active. Massive losses of -49.19% have been the result for the SELL prediction by StockNews_com. This prediction currently runs until 20.04.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sage Therapeutics Inc. | -1.652% | -1.652% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by StockNews_com for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for SAGE provided by MarketBeat
Stopped prediction by StockNews_com for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€18.10
20.08.23
20.08.23
-
20.08.24
20.08.24
-58.06%
21.08.24
21.08.24
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€20.40
12.08.23
12.08.23
-
12.08.24
12.08.24
-63.58%
13.08.24
13.08.24